Candriam S.C.A. Gsk PLC Transaction History

Candriam S.C.A.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$42.05 - $47.77 $3,994 - $4,538	-95 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$40.23 - $47.74 $3,821 - $4,535	95 New	95 $4,000
Q4 2021 Feb 10, 2022	SELL	$38.88 - $45.31 $3,576 - $4,168	-92 Closed	0 $0
Q2 2021 Jul 20, 2021	SELL	$36.52 - $41.46 $182 - $207	-5 Reduced 5.15%	92 $4,000
Q1 2021 Apr 29, 2021	BUY	$34.27 - $40.01 $1,953 - $2,280	57 Added 142.5%	97 $3,000
Q4 2020 Jan 22, 2021	BUY	$34.07 - $39.94 $783 - $918	23 Added 135.29%	40 $1,000
Q2 2020 Jul 23, 2020	BUY	$37.87 - $43.58 $643 - $740	17 New	17 $1,000
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $2,683 - $3,030	-71 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$39.75 - $42.69 $79 - $85	2 Added 2.9%	71 $3,000
Q2 2018 Aug 14, 2018	BUY	$39.61 - $42.76 $2,733 - $2,950	69 New	69 $3,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.